Klaria Pharma Holding AB (publ.) (STO:KLAR)
Sweden · Delayed Price · Currency is SEK 0.8040
+0.0040 (0.50%)
Jun 16, 2026, 10:37 AM CET
STO:KLAR Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 0.1 | 8.99 | 2.25 | 8.45 | 5.87 | - |
Other Revenue | - | - | - | - | - | 6.11 |
| 0.1 | 8.99 | 2.25 | 8.45 | 5.87 | 6.11 | |
Revenue Growth (YoY) | -99.10% | 299.69% | -73.41% | 44.07% | -3.99% | -15.35% |
Gross Profit | 0.1 | 8.99 | 2.25 | 8.45 | 5.87 | 6.11 |
Selling, General & Admin | 13.98 | 14.16 | 11.43 | 15.91 | 10.16 | 9.86 |
Research & Development | 21.55 | 28.3 | 22.11 | 24.95 | 51.36 | 63.49 |
Other Operating Expenses | - | - | - | -0.21 | -0.2 | 13.74 |
Operating Expenses | 35.53 | 42.46 | 33.53 | 40.64 | 61.31 | 87.09 |
Operating Income | -35.43 | -33.47 | -31.29 | -32.18 | -55.44 | -80.97 |
Interest Expense | -10.53 | -13.53 | -16.39 | -3.66 | -7.83 | -3.17 |
Interest & Investment Income | - | 0 | 0.01 | 0.01 | 0 | 0 |
Currency Exchange Gain (Loss) | - | -0.06 | -0.04 | 0.02 | -0.38 | 0.06 |
Other Non Operating Income (Expenses) | 0.02 | -0 | -0.03 | -0.02 | -0.02 | 30.53 |
Pretax Income | -45.95 | -47.06 | -47.73 | -35.84 | -63.66 | -53.55 |
Income Tax Expense | - | - | 0.02 | -0.06 | 0.12 | -0.01 |
Earnings From Continuing Operations | -45.95 | -47.06 | -47.75 | -35.78 | -63.77 | -53.53 |
Net Income | -45.95 | -47.06 | -47.75 | -35.78 | -63.77 | -53.53 |
Net Income to Common | -45.95 | -47.06 | -47.75 | -35.78 | -63.77 | -53.53 |
Shares Outstanding (Basic) | 214 | 189 | 125 | 101 | 58 | 52 |
Shares Outstanding (Diluted) | 214 | 189 | 125 | 101 | 58 | 52 |
Shares Change (YoY) | 59.64% | 51.58% | 23.63% | 73.49% | 12.15% | 19.58% |
EPS (Basic) | -0.21 | -0.25 | -0.38 | -0.36 | -1.10 | -1.03 |
EPS (Diluted) | -0.22 | -0.25 | -0.38 | -0.36 | -1.10 | -1.03 |
Free Cash Flow | -36.04 | -34.2 | -11.91 | -9.06 | -49.77 | -24.8 |
Free Cash Flow Per Share | -0.17 | -0.18 | -0.10 | -0.09 | -0.86 | -0.48 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -35432.00% | -372.55% | -1391.68% | -380.70% | -944.79% | -1324.82% |
Profit Margin | -45950.00% | -523.75% | -2124.11% | -423.28% | -1086.81% | -875.88% |
Free Cash Flow Margin | -36041.00% | -380.67% | -529.67% | -107.14% | -848.18% | -405.71% |
EBITDA | -24.26 | -19.54 | -25.59 | -21.15 | -45.09 | -70.61 |
EBITDA Margin | - | -217.46% | - | -250.14% | - | - |
D&A For EBITDA | 11.17 | 13.94 | 5.7 | 11.04 | 10.35 | 10.37 |
EBIT | -35.43 | -33.47 | -31.29 | -32.18 | -55.44 | -80.97 |